A new method to measure intestinal activity of P-glycoprotein in avian and mammalian species

Journal of Comparative Physiology B: Biochemical, Systemic, and Environmental Physiology

Volumn 175, Issue 1, 2005, Pages 57-66

  Green, Adam K ^a   Barnes, David M ^a   Karasov, William H ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Aflatoxin; Everted sleeve; Flavonoids; P glycoprotein; Sterigmatocystin

Indexed keywords

CYCLOSPORIN; DIGOXIN; ENZYME INHIBITOR; GLYCOPROTEIN P; IMMUNOSUPPRESSIVE AGENT; XENOBIOTIC AGENT;

ANIMAL; ARTICLE; CHICKEN; COMPARATIVE STUDY; DIET; INTESTINE MUCOSA; MAMMAL; METABOLISM; PHYSIOLOGY; RAT; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SPRAGUE DAWLEY RAT; VALIDATION STUDY; WILD ANIMAL;

ANIMALS; ANIMALS, WILD; CHICKENS; CYCLOSPORINE; DIET; DIGOXIN; ENZYME INHIBITORS; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL MUCOSA; MAMMALS; P-GLYCOPROTEIN; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; XENOBIOTICS;

AVES; GALLIFORMES; GALLUS GALLUS; MAMMALIA; RATTUS NORVEGICUS; RODENTIA;

EID: 12844256659     PISSN: 01741578     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00360-004-0462-0     Document Type: Article

References (43)

1. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM (1999) Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39:361-398
2. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM (2003) P-glycoprotein: from genomics to mechanism. Oncogene 22:7468-7485
3. Bard SM (2000) Multixenobiotic resistance as a cellular defense mechanism in aquatic organisms. Aquat Toxicol 48:357-389
4. Barnes DM (2001) Expression of P-glycoprotein in chickens. Comp Biochem Physiol A 130:301-310
5. Barthe L, Bessouet M, Woodley JF, Houin G (1998) The improved everted gut sac: a simple method to study intestinal P-glycoprotein. Int J Pharm Amsterdam 173(1):255-258
6. Bhat UG, Winter MA, Pearce HL, Beck WT (1995) A structure-function relationship among reserpine and yohimbine analogs in their ability to increase expression of MDR-1 and P-glycoprotein in a human colon-carcinoma cell-line. Mol Pharmacol 48:682-689
7. Brady JM, Cherrington NJ, Hartley DP, Buist SC, Li N, Klaassen CD (2002) Tissue distribution and chemical induction of multiple drug resistance genes in rats. Drug Metab Dispos 30:838-844
8. Burt RK, Thorgeirsson SS (1988) Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics. J Natl Cancer Inst 80:1383-1386
9. Castro AF, Altenberg GA (1997) Inhibition of drug transport by genistein in multidrug- resistant cells expressing P-glycoprotein. Biochem Pharmacol 53:89-93
10. Conseil G, Baubichon-Cortay H, Dayan G, Jault JM, Barron D, Di Pietro A (1998) Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. Proc Natl Acad Sci USA 95:9831-9836
11. Critchfield JW, Welsh CJ, Phang JM, Yeh GC (1994) Modulation of adriamycin(R) accumulation and efflux by flavonoids in HCT-15 colon cells - activation of P-glycoprotein as a putative mechanism. Biochem Pharmacol 48:1437-1445
12. Edelmann HML, Duchek P, Rosenthal FE, Foger N, Glackin C, Kane SE, Kuchler K (1999) CMDR1, a chicken P-glycoprotein, confers multidrug resistance and interacts with estradiol. Biol Chem 380:231-241
13. Epel D (1998) Use of multidrug transporters as first lines of defense against toxins in aquatic organisms. Comp Biochem Physiol A 120:23-28
14. Fardel O, Lecureur V, Corlu A, Guillouzo A (1996) P-glycoprotein induction in rat liver epithelial cells in response to acute 3-methylcholanthrene treatment. Biochem Pharmacol 51:1427-1436
15. Ford JM, Hait WN (1990) Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 42:155-99
16. Geick A, Eichelbaum M, Burk O (2001) Nuclear receptor response elements mediate induction of intestinal MDR-1 by rifampin. J Biol Chem 276:14581-14587
17. Greiner B, Eichelbaum M, Fritz P, Kreichgauer HP, von Richter O, Zundler J, Kroemer HK (1999) The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J Clin Invest 104:147-153
18. Hunter J, Hirst BH (1997) Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption. Adv Drug Deliv Rev 25:129-157
19. Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152-162
20. Karasov WH, Debnam ES (1987) Rapid adaptation of intestinal glucose-transport - a brush-border or basolateral phenomenon. Am J Physiol 253:G54-G61
21. Karasov W, Diamond JM (1983) A simple method for measuring intestinal solute uptake in vitro. J Comp Physiol B Biochem Syst Environ 152:105-116
22. Karasov WH, Solberg DH, Diamond JM (1985) What transport adaptations enable mammals to absorb sugars and amino-acids faster than reptiles. Am J Physiol 249:G271-G283
23. Kurelec B (1992) The multixenobiotic resistance mechanism in aquatic organisms. Crit Rev Toxicol22:23-43
24. Lan LB, Ayesh S, Lyubimov E, Pashinsky I, Stein WD (1996) Kinetic parameters for reversal of the multidrug pump as measured for drug accumulation and cell killing. Cancer Chemother Pharmacol 38:181-190
25. Lo YL, Huang JD (1999) Comparison of effects of natural or artificial rodent diet on etoposide absorption in rats. In Vivo 13:51-55
26. Makhey VD, Guo AL, Norris DA, Hu PD, Yan JS, Sinko PJ (1998) Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells. Pharm Res 15:1160-1167
27. Mickley LA, Bates SE, Richert ND, Currier S, Tanaka S, Foss F, Rosen N, Fojo AT (1989) Modulation of the expression of a multidrug resistance gene (MDR-1/P-glycoprotein) by differentiating agents. J Biol Chem 264:18031-18040
28. Mitsunaga Y, Takanaga H, Matsuo H, Naito M, Tsuruo T, Ohtani H, Sawada Y (2000) Effect of bioflavonoids on vincristine transport across blood-brain barrier. Eur J Pharmacol 395:193-201
29. Perlorff MD, Von Mohke LL, Greenblatt DJ (2001) The Saint John's Wort drug interaction: an in vitro analysis of P-glycoprotein (MDR-1) induction due to chronic exposure. FASEB J 15:A548
30. Phang JM, Poore CM, Lopaczynska J, Yeh GC (1993) Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells. Cancer Res 53:5977-5981
31. Sababi M, Borga O, Hultkvist-Bengtsson U (2001) The role of P-glycoprotein in limiting intestinal regional absorption of digoxin in rats. Eur J Pharm Sci 14:21-27
32. Salphati L, Benet LZ (1998) Modulation of P-glycoprotein expression by cytochrome P450 3A inducers in male and female rat livers. Biochem Pharmacol 55:387-395
33. Sandstrom R, Lennernas H (1999) Repeated oral rifampicin decreases the jejunal permeability of R/S-verapamil in rats. Drug Metab Dispos 27:951-955
34. Santoni-Rugiu E, Silverman JA (1997) Functional characterization of the rat mdr1b encoded P-glycoprotein: not all inducing agents are substrates. Carcinogenesis 18:2255-2263
35. Scambia G, Ranelletti FO, Panici PB, Devincenzo R, Bonanno G, Ferrandina G, Piantelli M, Bussa S, Rumi C, Cianfriglia M, Mancuso S (1994) Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell-line-P-glycoprotein as a possible target. Cancer Chemother Pharmacol 34:459-464
36. Shapiro AB, Ling V (1997) Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein. Biochem Pharmacol 53:587-596
37. Smital T, Sauerborn R, Pivcevic B, Krca S, Kurelec B (2000) Interspecies differences in P-glycoprotein mediated activity of multixenobiotic resistance mechanism in several marine and freshwater invertebrates. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 126c:175-186
38. Soldner A, Christians U, Susanto M, Wacher VJ, Silverman JA, Benet LZ (1999) Grapefruit juice activates P-glycoprotein-mediated drug transport. Pharm Res 16:478-485
39. Starck JM, Karasov WH, Afik D (2000) Intestinal nutrient uptake measurements and tissue damage: validating the everted sleeves method. Physiol Biochem Zool 73:454-460
40. Stephens RH, O'Neill CA, Warhurst A, Carlson GL, Rowland M, Warhurst G (2001) Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia. J Pharmacol Exp Ther 296:584-591
41. Van Straalen NM (1994) Biodiversity of ecotoxicological responses in animals. Neth J Zool 44:112-129
42. Versantvoort CHM, Schuurhuis GJ, Pinedo HM, Eekman CA, Kuiper CM (1993) Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells. Br J Cancer 68:939-946
43. Walker CH (1980). Species variations in some hepatic microsomal enzymes that metabolize xenobiotics. In: Bridges JW, Chasseaud LF (eds) Progress in drug metabolism. Wiley, New York, pp 113-164